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Abstract 
Purpose of Review 
Several bone disorders affecting the skeleton often are manifest in the maxillofacial region. This 
review presents the most common bone disorders in children and their dental–oral 
manifestations: fibrous dysplasia, Paget’s disease, osteogenesis imperfecta, renal 
osteodystrophy, hypophosphatasia, and osteoporosis. The specific intraoral characteristics will 
reviewed in detail. 
Recent Findings 
Recent studies confirmed the close relationship between the mandible and the maxilla with the 
most prevalent systemic bone disorders in children. 
Summary 
This review will help practitioners to integrate the oral health into the systemic health and 
improve the multidisciplinary approach of pediatric patients between medicine and dentistry. 
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Introduction 
Fibrous Dysplasia 
Fibrous dysplasia (FD) is the consequence of a proliferation and expansion of the bone marrow 
by fibrous tissue that contains an immature bone. Different components of bone structure are 
replaced by fibrous tissue containing different amounts of abnormal osseous tissue [1]. This 
condition is caused by activation of a mutation in the GNAS gene. The consequence of the 
GNAS activation is an overproduction of cAMP signaling pathway which decreases the ability 
of the immature bone cells to move into mature osteogenic cells [2]. Fibrous dysplasia may have 
solitary or multiple foci and may occur as a component of McCune–Albright syndrome. The 
long bones are most commonly involved, and the majority of lesions are symptomatic but the 
diagnosis may be an incidental finding during routine radiographic examination. 
The physiopathology of FD involves the replacement of the normal bone and bone marrow with 
fibro-osseous lesions. From a histology perspective, lesions consist of immature skeletal 
progenitor cells, which continue to proliferate in their multipotent state without differentiating 
into osteoblasts, adipocytes, or cells of the hematopoietic-support lines. Microscopically, an FD 
lesion is characterized by marrow fibrosis, abnormal trabeculae, and formation of abnormal 
mineralized tissue matrix [3, 4]. 
The clinical presentation of FD in children varies according to the location and extension of the 
lesions. The proximal femur and skull base are the bones more frequently involved. Fractures 
and expansion are often present with FD [5]. The diagnosis of FD is based on radiographic and 
in some cases, histological evaluation. Technetium-99 scintigraphy is helpful for identifying the 
foci of skeletal involvement. A comprehensive laboratory evaluation is mandatory in cases of 
suspected FD. Evaluation includes screening for hypophosphatemia, hyperthyroidism, and 
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abnormal growth hormone levels [6]. Treatment of FD is usually surgical [7]. 
Bisphosphonates are also used for pain control [6]. 
Dental Manifestations 
Fibrous dysplasia in children (and adults) affects the maxillofacial region. The most common 
involved bones are the cranial base of the skull, maxilla, and midface [8]. The lesions can be 
extensive causing expansion of the skull, maxilla, or mandible. Teeth displacement associated 
with malocclusion and midface deformities are also present [6]. In some severe cases, FD is 
associated with hypoplasia and hypomineralization of teeth. The latter is related to the high 
prevalence of caries observed in some FD patients. The typical radiographic pattern is a “ground-
glass” radiopaque appearance, with an ill-defined and non-corticated morphology (Fig. 1). 
Paget’s Disease 
Paget’s disease (PD) is a common bone disease in adults but uncommon in children. In children, 
PD is classified as juvenile Paget’s disease. In general, PD is characterized by an alteration in the 
critical homeostasis of the osteoblast and osteoclast. The condition is often asymptomatic and 
detected during routine radiographic evaluations [9]. Recently, the prevalence of PD is 
decreasing worldwide [10–12]. Probably, the most common manifestation of the disease is 
skeletal deformities usually visible in the skull and lower extremities. Pathological fractures 
occur often and most likely in the femur. Pain is common in patients with PD from skeletal, 
muscle, or neurological origin [13•]. The primary lesion in PD is a localized area of increased 
bone resorption together with hypertrophy of an immature new bone. The consequence is bone 
expansion with structural weakness. The etiology of PD is multifactorial. Both genetic and 
environmental factors have been related with the initiation and progression of the condition. 
Among the environmental factors, dietary deficiencies and chronic infection with 
paramyxoviruses are the most relevant etiology for PD [14]. Gene mutations have been also 
identified with the development of PD, in particular genes mediating cytokine signaling [15]. 
Juvenile Paget’s disease has a strong genetic predisposition. 
Juvenile Paget’s disease (JPD) is an autosomal recessive disorder associated with increased bone 
turnover due to activation of the osteoclast in the bone matrix. JPD affects all the bones and 
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causes a progressive deformities, short stature, growth retardation, as well as facial deformities 
such as maxillary expansion and progressive macrocephaly. Because of the bone expansion, 
other structures are affected especially the auditory and optic nerves. The morbidity and 
mortality of JPD is high. The majority of patients are in wheel chair before the age of 15 if the 
condition is not treated [16]. Oral bisphosphonates are the treatment of choice for JPD. Early 
treatment with these medications decreases the bone turnover and prevents the development of 
deformities [17]. 
Osteogenesis Imperfecta 
Osteogenesis imperfecta (OI) is an uncommon genetic bone disorder associated with the fragile 
(brittle) bones and fractures in children and adults. Several genes have been identified as 
possible etiology for this condition; some of the genes are associated with the collagen 
production. OI occurs in approximately 1 in 10,000 to 20,000 live births [18]. The typical 
clinical presentation is bone fragility which may be associated with skeletal deformities, joint 
laxity, and scoliosis. Several classifications (subtypes) of OI have been proposed according to 
the phenotype and genotype of the clinical history. Based on the phenotype and mode of 
inheritance, OI is classified in four subtypes. The most severe form is OI type II presenting with 
extreme bone fragility and multiple spontaneous fractures. The majority of patients with OI type 
II die before 4 weeks of age [19]. The most common subtype is OI type I, which is associated 
mild to moderate bone fragility. The risk of fractures and fragility of osseous tissue is a 
consequence of a combination of decreased bone quality and reduced bone mass [20]. The main 
goal for the treatment of OI is to decrease the risk of fractures and pain. With children, physical 
therapy and rehabilitation are critical therapeutic factors for avoiding fractures and improving 
weight bearing tolerance and increasing bone strength [21]. 
Dental Manifestations 
The dental manifestations of OI are similar to the presentation of dentinogenesis imperfecta. The 
primary and adult dentition are affected. The hue of OI teeth is blue to brown translucent 
(Fig. 2). The Teeth are smaller than normal, and a constriction of the cementum-enamel junction 
is present. Root size is decreased compared to a normal teeth. Furthermore, pulp chambers are 
progressively diminished and in some cases, completely obliterated [22]. Discoloration is less 
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pronounced in the maxillary permanent incisors compared to the primary teeth. Also, children 
with OI present with an increased prevalence of class III malocclusion probably related to an 
underdeveloped maxilla [19] (Fig. 2). 
Renal Osteodystrophy 
The term renal osteodystrophy (RO) is used to identify several osseous conditions associated 
with chronic kidney disease (CKD). In children, CKD is the usual end point of congenital, 
acquired, inherited, or metabolic renal disease. The underlying etiology is related to the age of 
the patient. In children 5 years old or less, the most common cause of CKD is congenital renal 
hypoplasia, congenital nephrotic syndrome, polycystic kidney disease, obstructive uropathy, etc. 
After 5 years of age, acquired diseases increasingly interact with inherited disorders to produce 
the most common etiology of CKD. 
Renal osteodystrophy in children is a high-turnover metabolic bone disease caused by secondary 
hyperparathyroidism related to CKD. The pathophysiology of RO reflects a chronic decrease in 
the glomerular filtration rate (GFR). The decrease in functional kidney mass leads to a decline in 
renal 1α-hydroxylase activity, with a decreased production of the active metabolite of vitamin D 
(1,25 dihydroxycholecalciferol). The decline in the active metabolite of vitamin D results in a 
decrease of the gastrointestinal absorption of calcium, which depresses ionic calcium (Ca
++
) in 
the serum triggering an increased secretion of parathyroid hormone [23]. The cascade of 
metabolic events includes increased production and function of osteoclasts to help increase 
serum Ca
++
 levels. The clinical manifestations of RO include muscle weakness, bone pain, and 
relatively atraumatic fractures. Alterations in skeletal mineralization are common in children 
with RO, and the primary treatment for the disease is the administration of vitamin D. The main 
objectives for treatment are to prevent bone deformity and normalize growth velocity [23]. 
Dental Manifestations 
Renal osteodystrophy is associated with several clinical manifestations in the oral-facial 
complex, and the most common is diffuse jaw enlargement [24]. Radiographic changes in RO 
are similar to the changes observed in fibrous dysplasia or Paget’s disease. This pathophysiology 
is consistent with ground-glass bone appearance, hypercementosis and bone resorption with loss 
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of the lamina dura [25]. The latter is a common dental radiographic feature for all high-turnover 
metabolic bone diseases. Renal osteodystrophy is also associated with a delayed eruption pattern, 
dental spacing, tooth mobility, propensity for jaw fractures, and poor definition of anatomical 
landmarks [26]. 
Hypophosphatasia 
Hypophosphatasia (HPP) is an inherited rare bone condition characterized by 
hypomineralization. This condition is classified into six subtypes according to age of onset: 
perinatal (lethal), perinatal benign, infantile, childhood, adult, and odontohypophosphatasia. 
Hypophosphatasia is characterized by a deficiency of tissue-nonspecific alkaline phosphatase 
(TNAP) [27]. This enzyme is critical for tissue mineralization. Lack of the enzyme carries 
several metabolic consequences including hypomineralization of bones and teeth [28]. Bone 
fragility and deformities are typical features of this condition. During childhood, symptoms 
are problems in walking, growth retardation, and muscle weakness [29]. 
Dental Manifestations 
Premature loss of primary teeth (usually before the age of 3) is a key feature of hypophosphatasia 
(Fig. 3). The teeth usually exfoliate with intact roots. Early mobility of primary teeth is one of 
the first signs. As soon as the problem is noted, the child should be examined by a dentist, 
preferably a pediatric dentist, particularly if the child is < 4 years of age. In older patients, 
hypophosphatasia is characterized by early loss of permanent teeth. Periodontal disease without 
substantial dental plaque has been reported for patients with hypophosphatasia [30]. Abnormal 
cementum is noted on teeth that are exfoliated prematurely and may be the primary factor in 
deterioration of the periodontium leading to early exfoliation [31]. Eating disorders associated 
with hypercalcemia and increased caries prevalence may be clinical features of 
hypophosphatasia [32] (Fig. 3). 
Osteoporosis 
Osteoporosis is not common in children, but there has been a significant increase in the diagnosis 
of the disorder in children in the last 5 years [33]. In general, patients with juvenile osteoporosis 
suffer from a decrease in bone volume that is associated with increased risk for fractures [6]. 
7 
Histologic analysis of bone biopsies for differing manifestations of juvenile osteoporosis reveals 
that osseous tissue mineralizes normally, but there is a sharp reduction in bone mass, particularly 
with respect to the trabecular bone. 
Osteoporosis in children can be primary or secondary to chronic diseases. Primary osteoporosis 
occurs because of an intrinsic skeletal defect of genetic or idiopathic origin [34•]. The most 
common causes of secondary osteoporosis are immobility, leukemia, inflammation, 
hypogonadism, and poor nutrition. Bone fragility with spontaneous or pathologic fractures is the 
usual clinical presentation of osteoporosis in children. The diagnosis of juvenile osteoporosis 
includes laboratory blood work, e.g., serum alkaline phosphatase, calcium phosphate, and 
vitamin D. Dual energy X-ray absorptiometry (DXA) is the gold standard in the diagnosis of 
osteoporosis [34•]. Early intervention is fundamental to decrease the progression of the 
condition. Bisphosphonates are the treatment of choice for pediatric osteoporosis [35]. 
Dental Manifestations 
Osteoporosis in children features similar maxillofacial characteristics as those noted in 
osteoporotic adults. Radiographic characteristics include a thin mandibular inferior cortex 
together with a decrease in the number and thickness of trabecular bone plates. Specific erosions 
into or through the inferior border of the mandible are common in children with osteoporosis 
[36]. 
Conclusion 
Dental manifestation of skeletal disease in children is most commonly associated with fibrous 
dysplasia, juvenile Paget’s disease, osteogenesis imperfecta, renal osteodystrophy, 
hypophosphatasia, and osteoporosis. In general, the systemic manifestations of skeletal disease in 
children is similar to adults, but the rapid dentofacial growth and development of children render 
the orofacial region particularly vulnerable to specific signs and symptoms. It is important for 
parents and health professionals to carefully monitor the orofacial region for unusual form and 
function. Dental problems may be the first significant manifestation of serious skeletal disease. 
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Fig. 1 Fibrous dysplasia: right mandible (yellow arrows) 
Fig. 2 Mandibular incisors of a 15-year-old girl affected with osteogenesis imperfecta 
Fig. 3 Hypophosphatasia in a 3.5-year-old girl. Early loss of primary mandibular incisors 
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